The demise of Oregon's Medically Needy Program: Effects of losing prescription drug coverage

Journal of General Internal Medicine

Volumn 22, Issue 6, 2007, Pages 847-851

  Zerzan, Judy ^a,b,c   Edlund, Tina ^d   Krois, Lisa ^d   Smith, Jeanene ^d  

^a Puget Sound Medical Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Oregon Health Policy and Research   (United States)

Author keywords

Prescription drugs; Survey research; Vulnerable populations

Indexed keywords

ADULT; AGED; BUDGET; CHRONIC PATIENT; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DRUG USE; EMERGENCY CARE; FEMALE; FOOD; HEALTH; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH PROGRAM; HEALTH SURVEY; HOSPITALIZATION; HUMAN; LOWEST INCOME GROUP; MALE; MEDICAL INFORMATION; MONEY; PRESCRIPTION; RANDOMIZATION; REVIEW; SELF REPORT; TELEPHONE; TREATMENT WITHDRAWAL;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COST CONTROL; DELIVERY OF HEALTH CARE; FEES, PHARMACEUTICAL; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; MEDICAID; MIDDLE AGED; OREGON; PATIENT COMPLIANCE; POVERTY; PRESCRIPTION FEES; PRESCRIPTIONS, DRUG; STATE HEALTH PLANS; UNITED STATES;

EID: 34248589358     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0178-4     Document Type: Review

References (36)

1. Soumerai SB, Ross-Degnan D. Inadequate prescription-drug coverage for Medicare enrollees - a call to action. N Engl J Med. 1999;340:722-8.
2. Stuart B, Zacker C. Who bears the burden of Medicaid drug copayment policies? Health Aff (Project Hope). 1999;18:201-12.
3. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004;27:384-91.
4. Safran DG. Seniors and prescription drugs: findings from a 2001 survey of seniors in eight states. The Commonwealth Fund/Kaiser Family Foundation/Tufts-New England Medical Center; July 2002.
5. Xu KT. Financial disparities in prescription drug use between elderly and nonelderly Americans. Health Aff (Project Hope). 2003;22:210-21.
6. Tseng CW, Brook RH, Keeler E, Steers WN, Waitzfelder BE, Mangione CM. Effect of generic-only drug benefits on seniors' medication use and financial burden. Am J Manag Care. 2006;12:525-32.
7. Lurie N, Ward NB, Shapiro MF, Brook RH. Termination from Medi-Cal - does it affect health? N Engl J Med. 1984;311:480-4.
8. Lurie N, Ward NB, Shapiro MF, Gallego C, Vaghaiwalla R, Brook RH. Termination of Medi-Cal benefits. A follow-up study one year later. N Engl J Med. 1986;314:1266-8.
9. Saver BG, Doescher MP, Jackson JE, Fishman P. Seniors with chronic health conditions and prescription drugs: benefits, wealth, and health. Value Health. 2004;7:133-43.
10. Kleinke JD. The price of progress: prescription drugs in the health care market. Health Aff (Project Hope). 2001;20:43-60.
11. Tseng CW, Brook RH, Keeler E, Mangione CM. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients. JAMA. 2003;290:222-7.
12. Harris BL, Stergachis A, Ried LD. The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization. Med Care. 1990;28:907-17.
13. Johnson RE, Goodman MJ, Hornbrook MC, Eldredge MB. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Med Care. 1997;35:1119-31.
14. Crowley JS, Ashner D, Elam L. Medicaid outpatient prescription drug benefits: findings from a national survey. 2003. Available at: http://www.kff.org/medicaid/4164.cfm. Accessed October 18, 2006.
15. Oregon Department of Human Services Memo. Oregon Department of Human Services, State of Oregon; June 2003.
16. CMS. Prescription drug coverage: General information 2006. Centers for Medicaid and Medicare Services. Available at: http://www.cms.hhs.gov/ PrescriptionDrugCovGenIn/. Accessed October 18, 2006.
17. Brodie M, Blendon R. National survey on prescription drugs. Health Desk: A Partnership of the Kaiser Family Foundation and the Newshour with Jim Lehrer; 2000.
18. Berk ML, Schur CL, Mohr P. Using survey data to estimate prescription drug costs. Health Aff (Project Hope). 1990;9:146-56.
19. Barnes PM, Adams PF, Schiller JS. Summary of health statistics for the US population: National Health Interview Survey, 2001. National Center for Health Statistics. Vital Health Stat. 2003;27.
20. CDC Behavioral Risk Factor Surveillance System, Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion. 2004. Available at: http://www.cdc.gov/brfss/. Accessed October 18, 2006.
21. MedPAC. Dual eligible beneficiaries: an overview. Report to the Congress: New approaches in Medicare, section 3. 2004:71-91.Available at: http://www.medpac.gov/publications/congressional_reports/Jun06DataBook Sec3.pdf. Accessed October 18, 2006.
22. Cunningham PJ. Medicaid cost containment and access to prescription drugs. Health Aff (Project Hope). 2005;24:780-9.
23. Piette JD, Heisler M. Problems due to medication costs among VA and non-VA patients with chronic illnesses. Am J Manag Care. 2004;10:861-8.
24. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Pub Health. 2004;94:1782-7.
25. Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292:952-60.
26. Soumerai SB, Avorn J, Ross-Degnan D, Gortmaker S. Payment restrictions for prescription drugs under Medicaid: effects on therapy, cost, and equity. N Engl J Med. 1987;317:550-6.
27. Soumerai SB, Ross-Degnan D, Avorn J, McLaughlin T, Choodnovskiy I. Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes. N Engl J Med. 1991;325:1072-7.
28. Motheral B, Fairman KA. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization. Med Care. 2001;39:1293-304.
29. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421-9.
30. Rector TS, Venus PJ. Do drug benefits help Medicare beneficiaries afford prescribed drugs? Health Aff (Project Hope). 2004;23:213.
31. Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Project Hope). 2003;22:220-9.
32. Caskie GI, Willis SL. Congruence of self-reported medications with pharmacy prescription records in low-income older adults. Gerontologist. 2004;44:176-85.
33. Boudreau DM, Daling JR, Malone KE, Gardner JS, Blough DK, Heckbert SR. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol. 2004;159:308-17.
34. Boudreau DM, Doescher MP, Saver BG, Jackson JE, Fishman PA. Reliability of Group Health Cooperative automated pharmacy data by drug benefit status. Pharmacoepidemiol Drug Saf. 2005;14:877-84.
35. Iglehart JK. The dilemma of Medicaid. N Engl J Med. 2003;348:2140-8.
36. Baugh DK, Pine PL, Blackwell S, Ciborowski G. Medicaid prescription drug spending in the 1990s: a decade of change. Health Care Financ Rev. 2004;25:5-23.